TP53 and breast carcinoma: We selected MCF‐7 (hormone receptor (HR): positive/human epidermal growth factor receptor 2 (HER2): negative) breast cancer cells harboring wild‐type TP53 as a suitable model for studying the characteristics of TIS induced by different agents.